65 related articles for article (PubMed ID: 3055166)
1. [Radiotherapy of cerebral metastases. 196 cases treated from 1973 to 1981].
Chassard JL; Zouai ME; Gérard JP; Dutou L; Mornex F; Lacroze M; Ardiet JM; Chauvin F
Rev Neurol (Paris); 1988; 144(8-9):489-93. PubMed ID: 3055166
[TBL] [Abstract][Full Text] [Related]
2. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
3. [Stereotaxic irradiation of brain metastasis in elderly patients].
Noël G; Noël S; Feuvret L; Valery CA; Cornu P; Boisserie G; Hasboun D; Tep B; Delattre JY; Baillet F; Mazeron JJ
Bull Cancer; 2003 Oct; 90(10):896-904. PubMed ID: 14706918
[TBL] [Abstract][Full Text] [Related]
4. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
5. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
6. Volumetric follow up of brain metastases: a useful method to evaluate treatment outcome and predict survival after Gamma Knife surgery?
Feigl GC; Horstmann GA
J Neurosurg; 2006 Dec; 105 Suppl():91-8. PubMed ID: 18503338
[TBL] [Abstract][Full Text] [Related]
7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
8. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
9. [Influence of postoperative radiation therapy of cerebral metastases on survival time and disease related to living condition].
Winking M; Bräuer N; Lücke M; Nestler U; Böker DK
Zentralbl Neurochir; 2002; 63(4):163-9. PubMed ID: 12518260
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
11. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
14. [Primary cerebral non-Hodgkin's lymphomas. The results of radiotherapy].
Hetzel-Sesterheim M; Schnabel K; Nestle U; Hamann G; Berberich W
Strahlenther Onkol; 1996 Apr; 172(4):198-204. PubMed ID: 8623082
[TBL] [Abstract][Full Text] [Related]
15. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
Yue X; Zang QC
Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
[TBL] [Abstract][Full Text] [Related]
16. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
17. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
18. [The radiotherapy of brain metastases in bronchial carcinoma].
Nieder C; Niewald M; Schnabel K
Strahlenther Onkol; 1994 Jun; 170(6):335-41. PubMed ID: 8023242
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for cerebral metastases.
Sneed PK; Larson DA; Wara WM
Neurosurg Clin N Am; 1996 Jul; 7(3):505-15. PubMed ID: 8823778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
